Stem Cells http://www.epitomics.com
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online June 28, 2007
Stem Cells Vol. 25 No. 10 October 2007, pp. 2396 -2407
doi:10.1634/stemcells.2007-0313; www.StemCells.com
© 2007 AlphaMed Press

OPEN ACCESS ARTICLE
This Article
Free via Open Access: OA
Right arrow OA Full Text
Right arrow Full Text (PDF)
Right arrowOA All Versions of this Article:
2007-0313v1
25/10/2396    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shetty, A. K.
Right arrow Articles by Hattiangady, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shetty, A. K.
Right arrow Articles by Hattiangady, B.

TISSUE-SPECIFIC STEM CELLS

Concise Review: Prospects of Stem Cell Therapy for Temporal Lobe Epilepsy

Ashok K. Shettya,b, Bharathi Hattiangadya,b

aDepartment of Surgery (Neurosurgery), Duke University Medical Center, Durham, North Carolina, USA;
bMedical Research and Surgery Services, Veterans Affairs Medical Center, Durham, North Carolina, USA

Key Words. Temporal lobe epilepsy • Adult neurogenesis • Dentate gyrus • Epilepsy • Hippocampal stem cells Hippocampal progenitors • Neural stem cells • Stem cell grafts

Correspondence: Ashok K. Shetty, M.Sc., Ph.D., Division of Neurosurgery, DUMC Box 3807, Duke University Medical Center, Durham, North Carolina 27710, USA. Telephone: (919) 286-0411, ext. 7096; Fax: (919) 286-4662; e-mail: Ashok.Shetty{at}duke.edu

Received April 26, 2007; accepted for publication June 18, 2007.
First published online in STEM CELLS EXPRESS   June 28, 2007.



Certain regions of the adult brain have the ability for partial self-repair after injury through production of new neurons via activation of neural stem/progenitor cells (NSCs). Nonetheless, there is no evidence yet for pervasive spontaneous replacement of dead neurons by newly formed neurons leading to functional recovery in the injured brain. Consequently, there is enormous interest for stimulating endogenous NSCs in the brain to produce new neurons or for grafting of NSCs isolated and expanded from different brain regions or embryonic stem cells into the injured brain. Temporal lobe epilepsy (TLE), characterized by hyperexcitability in the hippocampus and spontaneous seizures, is a possible clinical target for stem cell-based therapies. This is because these approaches have the potential to curb epileptogenesis and prevent chronic epilepsy development and learning and memory dysfunction after hippocampal damage related to status epilepticus or head injury. Grafting of NSCs may also be useful for restraining seizures during chronic epilepsy. The aim of this review is to evaluate current knowledge and outlook pertaining to stem cell-based therapies for TLE. The first section discusses the behavior of endogenous hippocampal NSCs in human TLE and animal models of TLE and evaluates the role of hippocampal neurogenesis in the pathophysiology and treatment of TLE. The second segment considers the prospects for preventing or suppressing seizures in TLE using exogenously applied stem cells. The final part analyzes problems that remain to be resolved before initiating clinical application of stem cell-based therapies for TLE.

Disclosure of potential conflicts of interest is found at the end of this article.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.epitomics.com
Copyright © 2007 by AlphaMed Press.